Subscribe: Market Wire - Medical and Healthcare: Health and Nutrition
http://img.marketwire.com/rss/mwMHHN.rss
Preview: Market Wire - Medical and Healthcare: Health and Nutrition

Marketwired - Health and Nutrition



Marketwired - Health and Nutrition



Last Build Date: Thu, 14 Dec 2017 07:37:50 EST

Copyright: Copyright: (C) Marketwired
 



Bonne nouvelle pour les patients atteints du SCI

Thu, 14 Dec 2017 07:06:00 EST

MONTRÉAL, QUÉBEC--(Marketwired - 14 déc. 2017) - FODY Food Co. («?FODY?»), chef de file nord-américain de la fabrication, du développement et de la commercialisation de produits réduits FODMAP pour les millions de personnes souffrant du syndrome de côlon irritable (SCI), a annoncé aujourd'hui la collecte de 2,25 millions de dollars dans le cadre d'un cycle de financement de titres de série A, mené par Avrio Capital («?Avrio?»), investisseur de premier plan au Canada en capital privé axé sur les produits alimentaires. Aki Georgacacos, directeur général d'Avrio, se joindra à Jonathan Ross Goodman, cofondateur et ancien chef de la direction de la société cotée en bourse Laboratoires Paladin inc. et fondateur et chef de la direction de la société cotée en bourse Thérapeutique Knight inc. (TSX:GUD), à titre d'investisseur principal et membre du conseil d'administration.




FODY Food Co. Signs Deal to Help IBS Sufferers

Thu, 14 Dec 2017 07:06:00 EST

MONTREAL, QUEBEC--(Marketwired - Dec. 14, 2017) - FODY Food Co. ("FODY"), North America's leader in manufacturing, developing and commercializing of low FODMAP foods for the millions of people suffering from irritable bowel syndrome ("IBS"), today announced that it has raised $2.25 million in a Series A financing round led by Avrio Capital ("Avrio"), Canada's premiere food-specific private equity investor. Aki Georgacacos, Managing Director and co-founder at Avrio, will join Jonathan Ross Goodman, co-founder and former CEO of publicly traded Paladin Labs Inc., and founder and CEO of publicly traded Knight Therapeutics Inc. (TSX:GUD) as lead investor and Board member.




Aphria Inc. Announces $100 Million Bought Deal

Wed, 13 Dec 2017 08:03:05 EST

LEAMINGTON, ONTARIO--(Marketwired - Dec. 13, 2017) -




Viveve Medical Named One of North America's Fastest Growing Companies

Tue, 12 Dec 2017 08:28:00 EST

Recognition reflects Viveve's rapid growth and global expansion of the patented Viveve(R) System




Hydropothecary annonce un plan d'expansion qui augmentera sa capacité de production à 108 000 kilogrammes par an de cannabis séché

Tue, 12 Dec 2017 06:30:00 EST

L'annonce de cette expansion est sur le point de faire de Hydropothecary l'un des producteurs de cannabis les plus importants au pays




Hydropothecary announces expansion plans to increase production capacity to 108,000 kilograms per year of dried cannabis

Tue, 12 Dec 2017 06:30:00 EST

Expansion announcement set to make Hydropothecary one of the top cannabis producers in the country




Rennova Health Announces an Upgrade of MedicalMime's Flagship EHR M2Select to Version 3.3

Mon, 11 Dec 2017 09:20:00 EST

WEST PALM BEACH, FL--(Marketwired - December 11, 2017) - Rennova Health, Inc. (OTCQB: RNVA) (OTCQB: RNVAW) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that opened its first rural hospital in Oneida, Tenn. on August 8, 2017, announces an upgrade of its flagship electronic health records (EHR) platform, M2Select to Version 3.3. This platform is available to office-based physicians, as well as to mental health providers working in substance abuse and drug and alcohol rehabilitation facilities.




Strength Sensei Nutraceuticals et Charles R. Poliquin lancent MaxSimil®

Mon, 11 Dec 2017 08:30:00 EST

LAVAL, QUÉBEC--(Marketwired - 11 déc. 2017) - Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce, en partenariat avec Strength Sensei Nutraceuticals, une entreprise de Charles R. Poliquin, le lancement d'Omega DriveMC, un produit contenant de l'AEP et de l'ADH, deux acides gras oméga-3, et qui, enrichi de MaxSimil®, se destine au milieu de la préparation physique.




Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®

Mon, 11 Dec 2017 08:30:00 EST

LAVAL, QUÉBEC--(Marketwired - Dec. 11, 2017) - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT)(TSX:NEPT) announces, in partnership with Charles R. Poliquin's Strength Sensei Nutraceuticals, the launch of MaxSimil® enhanced Omega DriveT omega-3 EPA and DHA product for the strength coaching community.




IntelGenx Receives USPTO Notice of Allowance for Montelukast Orange Book Eligible Patent

Mon, 11 Dec 2017 08:00:00 EST

SAINT-LAURENT, QUEBEC--(Marketwired - Dec. 11, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) ("IntelGenx"), a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilmT technology platform, today announced that the United States Patent and Trademark Office ("USPTO") has granted a Notice of Allowance for US Patent Application 15/299,054, entitled "Device and Method of Treating Conditions Associated with Neuroinflammation." This film formulation patent covers Montelukast oral film formulations designed for the treatment of neuroinflammation and is intended to protect IntelGenx' Montelukast VersaFilmT product.




CES 2018 : Terraillon will highlight their connected wellness HOMNI sleep solution at CES 2018

Thu, 07 Dec 2017 14:25:30 EST

CES Unveiled and CES TECH West Sands Expo, Booth #44 144